Search the Newsreel

Abbott Laboratories (ABT) Ties Lingo Glucose Data To AI Health Tools

Get insights on thousands of stocks from the global community of over 7 million individual investors at Simply Wall St. Abbott Laboratories (NYSE:ABT) and Google Health announced a multi year partnership to integrate Abbott's Lingo biowearable glucose data with Google's AI driven consumer health …

Abbott and Big Ten bring back 'We Give Blood' as U.S. faces blood supply crisis

"We Give Blood" brings together all 18 Big Ten® schools in a competition to drive the most blood donations and win $1 million from global healthcare company Abbott For only the second time in its history, the American Red Cross has declared a national …

Por que as ações da Abbott Laboratories estão subindo hoje? - Investing.com Brasil

Abbott and Google launch first-of-its-kind partnership to transform everyday health through glucose insights and AI

Multi-year collaboration combines ongoing glucose insights from Abbott's Lingo biowearable with Google Health's technology to create a more comprehensive view of personal health Partnership includes a large-scale research study to better inform artificial intelligence (AI) coaching available in the Google Health app and future …

Abbott vs. Medtronic: Is Consistent Growth Better Than a Turnaround Story?

Abbott Laboratories (NYSE:ABT) and Medtronic (NYSE:MDT) are both prominent names in the Medtech space. Abbott Laboratories (NYSE:ABT) delivered strong fiscal Q2 2026 results, beating quarterly estimates and raising its annual profit forecast as robust demand for its cancer diagnostics and medical devices businesses helped …

Abbott Laboratories (ABT) Could Be 10% Undervalued On Its $1.35b Buyback Update

Track your investments for FREE with Simply Wall St, the portfolio command center trusted by over 7 million individual investors worldwide. Abbott Laboratories buyback update Abbott Laboratories (ABT) has completed a share repurchase tranche that saw the company buy back 14,015,097 shares for about …

Análise e Previsão das Ações da Abbott Laboratories (ABT)

AbbVie vs. Abbott Laboratories: Which Healthcare Stock Is a Better Buy in 2026?

Choosing between a high-yield pharmaceutical powerhouse and a diversified healthcare leader requires looking at growth and stability. You must decide whether AbbVie (NYSE:ABBV) or Abbott Laboratories (NYSE:ABT) better fits your 2026 investment strategy. AbbVie focuses on high-margin specialized drugs, while Abbott operates across medical …

What Makes Abbott Laboratories (ABT) a Compelling Investment Opportunity with Reliable Growth

Matrix Asset Advisors, an asset management company, released its Q2 2026 investor letter. A copy of the letter can be downloaded here. The stock market rebounded strongly in the second quarter, with the S&P 500 gaining 15.2% in the quarter and 10.2% year-to-date. Investors …

Abbott Stock: Is Wall Street Bullish or Bearish?

Abbott Laboratories HQ photo- by Sundry Photography via iStock Lake County, Illinois-based Abbott Laboratories (ABT) discovers, develops, manufactures, and sells health care products worldwide. The company has a market cap of $182.9 billion and operates through Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and …

Matrix Asset Advisors' Large Cap Value Portfolio adds ABT and MCD; exits NSRGY

* Matrix Asset Advisors' Large Cap Value Portfolio gained in the mid-teens in Q2 2026, roughly in line with the S&P 500, which returned 15.2% and modestly ahead of the Russell 1000 Value Index. * The firm initiated new positions in Abbott Laboratories (NYSE: …

Abbott Laboratories vs. Eli Lilly: Which Healthcare Stock Is a Better Buy in 2026?

Key Points Abbott Laboratories maintains a diversified business model spanning diagnostics, medical devices, and nutrition products. Eli Lilly is experiencing rapid growth driven by its dominant presence in the cardiometabolic treatment market. Which healthcare stock offers the right balance of stability and growth for …

AbbVie Has Raised Its Dividend for 53 Straight Years and Still Looks Attractively Valued. Is This Dividend King the Smartest Buy in Healthcare Right Now?

AbbVie (NYSE: ABBV), one of the world's largest pharmaceutical companies, is usually considered a blue chip dividend stock rather than a higher-growth one. Yet over the past five years, its stock has rallied 125% and delivered a total return of 170% with reinvested dividends. …

Abbott (ABT) Lands Exclusive Rights To FDA Approved Blood Based CRC Test

Track your investments for FREE with Simply Wall St, the portfolio command center trusted by over 7 million individual investors worldwide. Abbott Laboratories (NYSE:ABT) has secured exclusive U.S. commercialization rights for Freenome's SimpleScreen CRC, a newly FDA approved blood based colorectal cancer screening test. …

Abbott (ABT) Raised Its Profit Forecast. What’s Driving Its Growth?

Abbott Laboratories (NYSE:ABT) delivered strong fiscal Q2 2026 results, beating quarterly estimates and raising its annual profit forecast as robust demand for its cancer diagnostics and medical devices businesses helped ease investor concerns surrounding procedure volumes. Sales for the quarter rose 13% on a …

Receita da Abbott atinge US$ 12,59 bilhões no 2T2026

This Dividend King Could Be One of the Safest Stocks to Own Right Now

A gold crown with sparkling dust by tomertu via Shutterstock Choosing the right dividend stock isn't just about chasing the highest yields. The best dividend stocks are often the ones that quietly raise their payouts year after year while continuing to grow the underlying …

Abbott Laboratories Stock Surges 11% as Company Lifts Full Year Profit Guidance